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Abstract
Background: Classic laryngotrachoebronchitis (LTB) is an inflammatory process, with
oedema and secretions that involve the entire laryngotracheobronchial tree. The severity of
lower airway disease in African children with LTB has previously been documented. The aim
of the present study was to determine whether steroids prevent reintubation in African
children with classic LTB.
Method and results: The study was a retrospective analysis from January 1993 to
December 1996. Eighty-two black children with LTB were mechanically ventilated in the
intensive care unit (ICU). By univariate regression, the estimated B coefficients for variables
such as age, pneumonia, days of intubation, arterial partial oxygen tension (PaO2) : fractional
inspired oxygen (FIO2) ratio, atelectasis and antibiotic use were not statistically significant
(P > 0.05) as predictors for reintubation. Using multiple regression (all independent variables
in combination), none of the variables acted as predictors of reintubation (P = 0.25).
Steroids were shown to have no effect alone or in association with other variables in altering
reintubation rates. An increase in the days of intubation showed a tendency towards
reintubation (P = 0.06) in the univariate analysis (odds ratio 1.00–1.14), but showed no
statistically significant difference in multivariate analysis. Of the variables used as predictors
of reintubation, none acted either as a preventive factor or as a risk factor.
Conclusion: The present results suggest that steroids should not be recommended at any
stage in treatment of intubated patients with classic LTB. Prospective studies should
evaluate the major risk factors for reintubation: duration of intubation, trauma to the airway at
intubation and during ICU stay, and dose and timing of steroids. They should also evaluate
whether upper airway disease is present alone or in association with lower airway disease.
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Introduction
Classic LTB is an inflammatory process, with oedema and
secretions that involve the entire laryngotracheobronchial
tree. The severity of lower airway disease in African chil-
dren with LTB has previously been documented [1]. In
1979, Cherry [2] stated that steroid therapy could not be
expected to offer benefit in classic LTB, and would probably
be detrimental. Intubated patients with laryngotracheitishttp://ccforum.com/content/4/5/314
have high risk of reintubation [3]. Also, the most clinically
important end-point for intubated LTB patients is reintuba-
tion. The higher rate of airway complications that occur
after extubation in children may be accounted for by their
smaller airway diameter.
The usefulness of steroids in upper airway obstruction is
debated. The major subgroups of individuals with upper
airway obstruction in the intensive care setting to which
the controversy of steroid use (ie do steroids prevent intu-
bation or postextubation stridor?) pertains to are as
follows: those with a normal airway on admission who may
develop postextubation stridor; those with an airway at risk
for airway oedema (multiple intubations, traumatic intuba-
tion, duration of endotracheal intubation >14 days); chil-
dren intubated with laryngotracheitis (ie only upper airway
abnormalities); children with laryngotracheitis who are not
intubated; and those with LTB who are intubated [1,3,
4–18]. The question of steroid effectiveness has largely
been addressed in the first four subsets [1,3,4–18]. No
study has as yet documented the effectiveness of steroids
in African children with classic LTB.
Steroids nonspecifically inhibit the inflammatory effects of
many potentially harmful stimuli, including trauma [6,19].
They exert their benefit on the airway by decreasing airway
swelling [6,19]. Our primary aim was to determine
whether steroids, by reducing subglottic swelling, can
reduce the reintubation rate in children with classic LTB.
The impacts of other treatments (antibiotics), demo-
graphic features (age, duration of intubation) and patho-
physiological features (PaO2:FIO2 ratio, pneumonia,
atelectasis) were also analyzed.
Patients and methods
This is a retrospective study of patients with LTB who
were intubated and ventilated in the ICU of our institution
during the period January 1993 to December 1996.
Over this 4-year period, 82 black children (58 males and
24 females) with a median age of 12.5 months (range
1–96 months) and median weight of 8.6 kg (range
3.7–25 kg) were treated. Of the 82 patients who were
intubated, 85% were intubated in the operating room by
a senior anaesthetist following a controlled gas induc-
tion. Patients with epiglottits, spasmodic croup and a
previous history of upper airway problems were excluded
from the present study.
The upper airway component (laryngotracheitis) of the
disease (LTB) was based on the following clinical and
chest radiographic criteria: barking cough, coryza, fever,
inspiratory stridor and the ‘steeple sign’ of the trachea in
children who had a preintubation chest radiograph (which
indicates upper airway narrowing). The following grading
system for inspiratory stridor was used: grade 1, inspiratory
stridor only; grade 2, as grade 1 plus expiratory stridor;
grade 3, as grade 2 plus pulsus paradoxus; and grade 4,
as grade 3 plus cyanosis/mental obtundation [20]. All
patients admitted into the ICU had either grade 3 or
grade 4 stridor. The lower airway (bronchitic) component of
the disease (LTB) was based on any of the following crite-
ria either alone or in combination on admission to the ICU:
PaO2:FIO2 ratio; the need for positive-pressure mechanical
ventilation; the presence of bronchopneumonia on chest
radiography; atelectasis; and use of antibiotics.
Bronchopneumonia was defined as an infiltrate in any one
or more of the four quadrants on the chest radiograph.
Specimens from the trachea were not routinely examined
or cultured to detect viral or bacterial isolates.
Steroids given were dexamethasone in 44 patients
(0.4 mg/kg every 12 h for four doses), hydrocortisone in
17 patients (2.1 mg/kg, every 6 h for 28 doses on
average) and prednisolone (1 mg/kg daily for an average
of 5 days) in nine patients. The timing of steroids was
either from admission, from just before extubation, or both
at admission and before extubation. Extubation criteria
were not documented, even though it is unit policy to wait
for an air leak of about 15–20% of the tidal volume
(Siemens 900C ventilator; Siemens, Solna, Stockholm,
Sweden) in patients with upper airway swelling in particu-
lar, as well as to adhere to traditional weaning criteria in
general [21].
Antibiotics were started at admission to the ICU either
empirically (for bronchopneumonia) or during ICU stay for
proven or suspected infection, on the basis of chest radio-
graphy, blood cultures and blood counts. Atelectasis was
diagnosed on the chest radiograph on the basis of
tracheal deviation, shift of the lung fissures and infiltrates.
The number of days of intubation was counted from the
time of initial intubation to the time of extubation. The
PaO2:FIO2 ratio was used to document severity of shunt
on admission (severity of lower airway disease). A grading
system was used as follows: grade 4, PaO2:FIO2 <100;
grade 3, PaO2:FIO2 <200; grade 2, PaO2:FIO2 <300;
grade 1, PaO2:FIO2 >300.
Statistical analysis
Database management and statistical analysis were per-
formed with SAS software, version 6.12 (SAS Institute
Inc, Cary, NC, USA). The age, weight and intubation days
(all non-normal distribution) as well as the PaO2:FIO2
ratios (ordinal data) are expressed as median (range). Uni-
variate and multivariate logistic analysis were tested for
reintubation with the following predictive variables: age,
steroids, pneumonia, intubation days, PaO2:FIO2 ratio,
atelectasis and antibiotics. The results were expressed as
estimated coefficients, P value and odds ratio (95% confi-
dence intervals) for each variable. P < 0.05 was consid-
ered statistically significant.Critical Care    Vol 4 No 5 Rajah et al
Results
The frequency distribution of steroid intake is given in
Fig. 1. Overall, 52 out of the 59 patients who were not
reintubated were given steroids, whereas 20 out of 23
patients who were reintubated were given steroids. Out of
the 23 reintubated patients, nine had bronchopneumonia
diagnosed on admission (first day in the ICU), 16 were
administered antibiotics during the ICU stay, and nine
developed atelectasis during the ICU stay. In the same
group, the median age was 11 months (range 2–36
months), the median PaO2:FIO2 ratio on admission was
grade 3 (range grades 1–3) and the median number of
days intubated was 9 (range 1–38).
The overall mortality of the group as a whole was approxi-
mately 3.66% (three out of 82 patients). All of these
patients died after extubation. The cause of death in two
of these patients was septic shock, with underlying malnu-
trition. Both of these patients were recovering from
measles acquired in the preceding 2 weeks. One of these
patients was given steroids. The third patient had a car-
diorespiratory arrest, which was sudden and unexpected.
No immediate cause was identified. This patient did not
receive any steroids.
An increase in the days of intubation showed a tendency
toward reintubation (P = 0.06) in univariate analysis (odds
ratio 1.00–1.14), but showed no statistically significant
difference in multivariate analysis. Estimated B coefficients
for variable such as age (Table 1) were not statistically sig-
nificant (P > 0.05) in univariate regression. Using multiple
regression, none of the independent variables acted as
predictors for reintubation (P = 0.25; (Table 2).
Steroids showed no tendency toward a significant associa-
tion with reintubation on either the univariate or multivariate
analysis (P = 0.88 and 0.64, respectively). The negative B
coefficient for steroids suggested that the greater the
steroid use, the more likely it was that reintubation would
be required. This trend is not surprising in the malnour-
ished, septic child who embarks on a course of steroids,
and whose disease process is potentially aggravated.
The positive B coefficients of atelectasis, antibiotic use,
intubation days and PaO2:FIO2 ratio, which together indi-
cate infection and lower airway disease, suggest a greater
likelihood of reintubation in the presence of these factors,
although none of these associations was statistically sig-
nificant. This tendency is to be expected in sick, intubated
children.
Figure 1
Frequency distribution of steroid intake.
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Table 1
Estimated coefficients, odds ratios and 95% confidence
intervals for predictors of reintubation in univariate logistic
regression
Estimated
Variable coefficient P OR 95% CI
Age –0.03 0.14 0.97 0.93–1.01
Steroids –0.11 0.88 0.90 0.21–3.82
Pneumonia –0.41 0.42 0.67 0.25–1.77
Intubationdays 0.06 0.06 1.07 1.00–1.14
PaO2:FIO2 ratio 0.12 0.41 1.12 0.85–1.48
Atelectasis 0.96 0.09 2.61 0.87–7.81
Antibiotics 0.93 0.08 2.53 0.91–7.05
CI, confidence interval; OR, odds ratio.
Table 2
Estimated coefficients, odds ratios and 95% confidence
intervals for predictors of reintubation in multivariate logistic
regression
Estimated
Variable coefficient P OR 95% CI
Intercept –1.43 0.52
Age –0.03 0.27 0.98 0.93–1.02
Steroids –0.39 0.64 0.68 0.13–3.42
Pneumonia –0.39 0.50 0.68 0.22–2.10
Intubation days 0.04 0.36 1.04 0.96–1.12
PaO2:FIO2 ratio 0.16 0.28 1.17 0.88–1.57
Atelectasis 0.36 0.59 1.43 0.61–5.87
Antibiotics 0.63 0.28 1.88 0.61–5.86
–2 Log L = 9.06, with seven degrees of freedom (P = 0.25). CI,
confidence interval; OR, odds ratio.http://ccforum.com/content/4/5/314
Discussion
No studies have documented a benefit for steroids in pre-
venting reintubation in classic LTB. The present study indi-
cates that steroids are ineffective in preventing
reintubation in children with LTB. The doses of steroids
employed in most studies involving patients with upper
airway obstruction are contentious. The ideal dose is pos-
sibly 0.6 mg/kg [11]. However numerous studies [10–12]
have documented that lesser doses of 0.2–0.3 mg/kg
have been successful in decreasing upper airway inflam-
mation. Tibballs et al [18] stated that the dose of pred-
nisolone used in their study, although less than the
suggested ideal, was nevertheless effective. The mean
dose of dexamethasone in the present study of 0.4 mg/kg
was therefore acceptable. However, the lack of standard-
ization of steroids with respect to timing of onset of use,
the dose used and the types used are major limitations to
this study.
Steroids were shown to have no effect alone or in associa-
tion with other variables in preventing reintubation. Of the
variables used as predictors of reintubation, none acted
either as a preventive or as a risk factor.
The natural history of classic LTB is different from that of
laryngotracheitis. Apart from significant lower airway
disease, a major factor is that patients with LTB have
endotracheal tubes in place for a longer period, and are
therefore at risk of ongoing upper airway inflammation and
nosocomial infection. The fact that steroids did not alter
the frequency of reintubation in classic LTB does not pro-
scribe against their use in patients with laryngotracheitis
as the primary diagnosis on admission to hospital.
Other variables, including patient age, pneumonia, days
intubated, atelectasis, antibiotic use and PaO2:FIO2 ratio,
were shown to have no effect on the incidence of reintu-
bation. In the present group of patients, it is probable that
these factors in combination rendered steroid use non-
beneficial, by acting as cocontributors to lower airway
pathology. Steroids would not be expected to be of
benefit in such a group.
A major concern with steroid use in African children, who
are possibly malnourished and who may present with bacte-
rial tracheitis and bronchopneumonia, is their propensity
toward sepsis and nosocomial infection. Failure to recog-
nize the particular historical, ecological, aetiological and clin-
ical perspectives in such patients could potentially worsen
their morbidity and mortality. Tunnessen and Feinstein [4]
designed a prospective study model in laryngotracheitis and
steroid usage, and outlined all areas of controversy.
The major limitations of the present study are that the
timing of onset of steroid use varied, the dose of steroids
was not standardized, different types of steroids were
used, and the duration of steroid use differed. Prospective
studies should evaluate carefully the major risk factors for
reintubation, including the following: duration of intubation;
trauma at time of intubation and during ICU stay; dose of
steroids; and timing of steroids. They should also evaluate
what particular subset of patients is involved with respect
to upper airway involvement. The use of the term croup
should be avoided as it is often used interchangeably to
describe distinctly different clinical entities. The side
effects of acute steroid therapy should also be docu-
mented. Every effort should be taken to prevent nosocomial
infection and maintain proper airway care (humidification
and proper sedation to minimize airway trauma), because
these factors may act as confounding variables for reintu-
bation. In addition, the degree of airway leakage should be
standardized, because this may further act as a confound-
ing variable for reintubation. Tracheal aspirates at the time
of intubation should be routinely examined because bacter-
ial isolates may predict the lack of response to steroids or
the need for earlier antibiotic therapy.
The results of the present retrospective study suggest that
steroids may not be beneficial in the treatment of African
patients who are intubated for classic LTB. A prospective
randomized controlled trial needs to be undertaken in this
particular population group to support these findings.
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